Agilent Technologies (A) Set to Announce Earnings on Wednesday

Agilent Technologies (NYSE:A) will be announcing its earnings results after the market closes on Wednesday, May 29th. Analysts expect the company to announce earnings of $1.19 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Tuesday, February 27th. The medical research company reported $1.29 EPS for the quarter, beating the consensus estimate of $1.22 by $0.07. The firm had revenue of $1.66 billion during the quarter, compared to analyst estimates of $1.59 billion. Agilent Technologies had a net margin of 18.35% and a return on equity of 27.09%. The business’s revenue for the quarter was down 5.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.37 EPS. On average, analysts expect Agilent Technologies to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Agilent Technologies Stock Performance

A opened at $150.66 on Monday. The company’s 50 day moving average is $144.06 and its 200 day moving average is $136.38. The company has a current ratio of 2.68, a quick ratio of 2.04 and a debt-to-equity ratio of 0.41. The company has a market cap of $44.15 billion, a price-to-earnings ratio of 35.87, a PEG ratio of 4.04 and a beta of 1.13. Agilent Technologies has a 12-month low of $96.80 and a 12-month high of $155.35.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd will be given a $0.236 dividend. The ex-dividend date is Tuesday, July 2nd. This represents a $0.94 annualized dividend and a yield of 0.63%. Agilent Technologies’s payout ratio is presently 22.38%.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, SVP Philip Binns sold 2,827 shares of the firm’s stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $147.54, for a total value of $417,095.58. Following the completion of the sale, the senior vice president now owns 9,997 shares of the company’s stock, valued at $1,474,957.38. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other Agilent Technologies news, CEO Michael R. Mcmullen sold 52,297 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $150.00, for a total transaction of $7,844,550.00. Following the completion of the transaction, the chief executive officer now directly owns 253,909 shares of the company’s stock, valued at approximately $38,086,350. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Philip Binns sold 2,827 shares of Agilent Technologies stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $147.54, for a total value of $417,095.58. Following the transaction, the senior vice president now owns 9,997 shares of the company’s stock, valued at approximately $1,474,957.38. The disclosure for this sale can be found here. Insiders sold 61,610 shares of company stock valued at $9,220,333 over the last 90 days.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. UBS Group upped their price objective on Agilent Technologies from $130.00 to $155.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 28th. Stifel Nicolaus raised Agilent Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the company from $145.00 to $163.00 in a research report on Friday, April 5th. Barclays lifted their price target on shares of Agilent Technologies from $125.00 to $135.00 and gave the company an “underweight” rating in a report on Wednesday, April 10th. Oppenheimer increased their price objective on shares of Agilent Technologies from $67.00 to $90.00 and gave the stock an “outperform” rating in a research note on Tuesday, March 26th. Finally, Evercore ISI lifted their target price on shares of Agilent Technologies from $132.00 to $145.00 and gave the company an “in-line” rating in a research note on Thursday, April 4th. One analyst has rated the stock with a sell rating, five have given a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $141.06.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.